Cargando…

Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?

Detalles Bibliográficos
Autores principales: Bujnak, Alyssa C., Tewari, Krishnansu S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192234/
https://www.ncbi.nlm.nih.gov/pubmed/33908714
http://dx.doi.org/10.3802/jgo.2021.32.e62
_version_ 1783706017584906240
author Bujnak, Alyssa C.
Tewari, Krishnansu S.
author_facet Bujnak, Alyssa C.
Tewari, Krishnansu S.
author_sort Bujnak, Alyssa C.
collection PubMed
description
format Online
Article
Text
id pubmed-8192234
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-81922342021-07-01 Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer? Bujnak, Alyssa C. Tewari, Krishnansu S. J Gynecol Oncol Editorial Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021-04-19 /pmc/articles/PMC8192234/ /pubmed/33908714 http://dx.doi.org/10.3802/jgo.2021.32.e62 Text en Copyright © 2021. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Bujnak, Alyssa C.
Tewari, Krishnansu S.
Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
title Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
title_full Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
title_fullStr Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
title_full_unstemmed Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
title_short Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
title_sort should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192234/
https://www.ncbi.nlm.nih.gov/pubmed/33908714
http://dx.doi.org/10.3802/jgo.2021.32.e62
work_keys_str_mv AT bujnakalyssac shouldadjuvantchemotherapybeformallystudiedamongpatientsfoundtohavepelviclymphnodemetastasesfollowingradicalhysterectomywithlymphadenectomyforearlystagecervicalcancer
AT tewarikrishnansus shouldadjuvantchemotherapybeformallystudiedamongpatientsfoundtohavepelviclymphnodemetastasesfollowingradicalhysterectomywithlymphadenectomyforearlystagecervicalcancer